Financial News
Articles published by Aerovate Therapeutics, Inc.
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Aerovate Therapeutics to Explore Strategic Alternatives
July 08, 2024
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
May 13, 2024
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
March 25, 2024
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights
November 13, 2023
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Aerovate Therapeutics Announces Second Quarter Financial Results and Business Highlights
August 14, 2023
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
May 15, 2023
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Aerovate Therapeutics Announces Full-Year 2022 Financial Results and Business Highlights
March 29, 2023
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Aerovate Therapeutics Announces Third Quarter 2022 Financial Results
November 14, 2022
Via GlobeNewswire
Tickers
AVTE
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Aerovate Therapeutics Presents Novel Phase 2b/Phase 3 IMPAHCT Trial Design at CHEST Annual Meeting 2022
October 18, 2022
Via GlobeNewswire
Tickers
AVTE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.